MFDS — authorised 14 December 2012
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
🇰🇷 Signifor in South Korea
MFDS authorised Signifor on 14 December 2012
Marketing authorisation
Signifor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Signifor approved in South Korea?
Yes. MFDS authorised it on 14 December 2012.
Who is the marketing authorisation holder for Signifor in South Korea?
NOVARTIS holds the South Korean marketing authorisation.